These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 11344048)

  • 21. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein.
    Lee KS; Hong SH; Bae SC
    Oncogene; 2002 Oct; 21(47):7156-63. PubMed ID: 12370805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway.
    Haÿ E; Lemonnier J; Fromigué O; Marie PJ
    J Biol Chem; 2001 Aug; 276(31):29028-36. PubMed ID: 11395480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of MAP kinase by the BMP-4/TAK1 pathway in Xenopus ectoderm.
    Goswami M; Uzgare AR; Sater AK
    Dev Biol; 2001 Aug; 236(2):259-70. PubMed ID: 11476570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation.
    Hu Y; Chan E; Wang SX; Li B
    Endocrinology; 2003 May; 144(5):2068-74. PubMed ID: 12697715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation.
    Suzuki A; Guicheux J; Palmer G; Miura Y; Oiso Y; Bonjour JP; Caverzasio J
    Bone; 2002 Jan; 30(1):91-8. PubMed ID: 11792570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opposing TNF-α/IL-1β- and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation.
    Huang RL; Yuan Y; Tu J; Zou GM; Li Q
    Cell Death Dis; 2014 Apr; 5(4):e1187. PubMed ID: 24743742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells.
    Sowa H; Kaji H; Yamaguchi T; Sugimoto T; Chihara K
    J Biol Chem; 2002 Sep; 277(39):36024-31. PubMed ID: 12130649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
    J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages.
    Chen D; Ji X; Harris MA; Feng JQ; Karsenty G; Celeste AJ; Rosen V; Mundy GR; Harris SE
    J Cell Biol; 1998 Jul; 142(1):295-305. PubMed ID: 9660882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.
    Cowan CM; Jiang X; Hsu T; Soo C; Zhang B; Wang JZ; Kuroda S; Wu B; Zhang Z; Zhang X; Ting K
    J Bone Miner Res; 2007 Jun; 22(6):918-30. PubMed ID: 17352654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5.
    Nishimura R; Hata K; Harris SE; Ikeda F; Yoneda T
    Bone; 2002 Aug; 31(2):303-12. PubMed ID: 12151083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-(5-oxohexyl)-3,7-Dimethylxanthine, a phosphodiesterase inhibitor, activates MAPK cascades and promotes osteoblast differentiation by a mechanism independent of PKA activation (pentoxifylline promotes osteoblast differentiation).
    Rawadi G; Ferrer C; Spinella-Jaegle S; Roman-Roman S; Bouali Y; Baron R
    Endocrinology; 2001 Nov; 142(11):4673-82. PubMed ID: 11606432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of cAMP-dependent protein kinase inhibitor gamma is required for BMP-2-induced osteoblastic differentiation.
    Zhao L; Yang S; Zhou GQ; Yang J; Ji D; Sabatakos G; Zhu T
    Int J Biochem Cell Biol; 2006; 38(12):2064-73. PubMed ID: 16870489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
    Lee CH; Huang YL; Liao JF; Chiou WF
    Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells.
    Lai CF; Cheng SL
    J Biol Chem; 2002 May; 277(18):15514-22. PubMed ID: 11854297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation.
    Lu Z; Wang G; Dunstan CR; Zreiqat H
    Stem Cells Dev; 2012 Sep; 21(13):2420-9. PubMed ID: 22296271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.
    Lee KS; Kim HJ; Li QL; Chi XZ; Ueta C; Komori T; Wozney JM; Kim EG; Choi JY; Ryoo HM; Bae SC
    Mol Cell Biol; 2000 Dec; 20(23):8783-92. PubMed ID: 11073979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lactoferrin stimulates osteoblast differentiation through PKA and p38 pathways independent of lactoferrin's receptor LRP1.
    Zhang W; Guo H; Jing H; Li Y; Wang X; Zhang H; Jiang L; Ren F
    J Bone Miner Res; 2014; 29(5):1232-43. PubMed ID: 24877241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation.
    Spinella-Jaegle S; Roman-Roman S; Faucheu C; Dunn FW; Kawai S; Galléa S; Stiot V; Blanchet AM; Courtois B; Baron R; Rawadi G
    Bone; 2001 Oct; 29(4):323-30. PubMed ID: 11595614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12.
    Nishimura R; Kato Y; Chen D; Harris SE; Mundy GR; Yoneda T
    J Biol Chem; 1998 Jan; 273(4):1872-9. PubMed ID: 9442019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.